Objective The study aimed to compare outcomes of traumatic brain injury (TBI) in patients on
pre-injury antiplatelet drugs vs. those, not on any antiplatelet or anticoagulant drugs …

There is an increasing number of trauma patients presenting on pre-injury antiplatelet (AP)
agents attributable to an aging population and expanding cardio-or cerebrovascular …

Objective: To determine the effects of pre-injury consumption of anti-platelet agents on the
30-day outcomes of patients with mild traumatic brain injury (TBI). Methods: This prospective …

Background: As the population continues to age, the number of patients undergoing
traumatic injury while on antiplatelet or anticoagulation therapies is increasing. Mortality has …

Objective: To evaluate the outcomes after Traumatic Brain Injury (TBI) in patients taking
Antiplatelet Agents (APAs). Methods: We reviewed the clinical records of 934 patients with …

Background Antiplatelet and anticoagulant medication are increasingly common and can
increase the risks of morbidity and mortality in traumatic brain injury (TBI) patients. Our study …

The objective of this systematic review and meta-analysis is to evaluate whether the pre-
injury use of antiplatelet therapy (APT) is associated with increased risk of traumatic …

Introduction. Anticoagulation abnormalities have been recognized for several decades as
potential risk factors for increasing the risk of traumatic intracranial haemorrhage in patients …

As the population ages, emergency physicians are confronted with a growing number of
trauma patients receiving antithrombotic and antiplatelet medication prior to injury. In cases …

Background Mild traumatic brain injury (TBI) is a common event and antiplatelet therapy
might represent a risk factor for bleeding. Objective The aim of this study was to evaluate the …